By 2025, the therapeutic use of cannabis for inflammation is anticipated to see significant changes. Scientists believe targeted formulations, potentially featuring novel phytocannabinoid blends and controlled routes of delivery, will arise. Despite present data is evolving, ongoing trials focusing on distinct forms of arthritis – like osteoarthr